FDA-recognized standard · Orthopedic

ASTM F2028: Standard Test Methods for Dynamic Evaluation of Glenoid Loosening

Yes. FDA recognizes ASTM F2028-25a as recognition 11-433, in part, entered 2025-12-22. FDA also lists ASTM F2028-17 (recognition 11-330, transition period ending 2027-12-19).

Recognized editions of ASTM F2028

FDA recognitions of ASTM F2028, newest first (FDA database snapshot of 2026-09-01)
RecognitionEditionEnteredExtentTransition ends
11-433 ASTM F2028-25a 2025-12-22 Partial —
11-330 ASTM F2028-17 2020-12-21 Partial 2027-12-19

What FDA does not recognize in ASTM F2028-25a

Recognition 11-433 is partial. FDA's statement of the extent, verbatim:

Partial recognition. The following part(s) of the standard is (are) not recognized: - Subclause 16.2.4 Procedure (number of cycles)

What FDA does not recognize in ASTM F2028-17

Recognition 11-330 is partial. FDA's statement of the extent, verbatim:

Partial recognition. The following part(s) of the standard is (are) not recognized: - Subclause 24.2.4 Procedure (number of cycles) - Subclause X2.9 in APPENDIX X2 Rationale for Reverse Shoulder Glenoid Loosening/Disassociation Test (number of cycles)

Regulations

FDA lists these classification regulations against ASTM F2028: 21 CFR 888.3640, 21 CFR 888.3650, 21 CFR 888.3660, 21 CFR 888.3670, 21 CFR 888.3680.

Product codes that cite ASTM F2028

7 FDA product codes cite ASTM F2028, including KWR, KWS, KWT, KYM, MBF.

Source: FDA Recognized Consensus Standards database, snapshot of 2026-09-01. Search every recognition in the Consensus Standards Lookup, or browse all standards with a page.